Background: Socioeconomic position (SEP) is an important determinant of health and it is dynamic across the entire lifespan. We sought to investigate the relationship between life-course SEP and chronic kidney disease (CKD) using 3 conceptual models: critical period, pathway and accumulation. Methods: Cross-sectional analysis of 4,996 participants from The Irish Longitudinal Study on Ageing, a nationally representative cohort of community-dwelling adults aged ≥50 years. We defined childhood and adulthood SEP according to father’s and respondent’s occupation respectively. SEP was categorised as high (reference), intermediate, low and never worked. CKD was defined as a glomerular filtration rate < 60 mL/min/1.73 m2 estimated from the combination of creatinine and cystatin C. We used logistic regression to estimate the age-adjusted association between SEP and CKD separately in men and women. Results: Low childhood SEP was strongly associated with CKD in women, after adjusting for adulthood SEP (OR 1.90 [95% CI 1.24–2.92]), supporting the critical period hypothesis. This association was not explained by traditional CKD risk factors. Women who experienced low childhood SEP and whose circumstances improved in adulthood also had increased odds of CKD, further supporting a critical period effect in childhood. There was comparatively less evidence in support of the pathway or accumulation models. We did not observe a statistically significant association between SEP and CKD in men. Conclusions: Our findings suggest that women exposed to disadvantaged SEP in childhood represent an at-risk group in whom there may be opportunities for identification of CKD and facilitation of health-promoting behaviours from an early age.

Keywords:
Chronic kidney disease, Critical period, Life course, Socioeconomic position
1.
Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, et al: Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375: 2073–2081.
2.
Bruck K, Stel VS, Gambaro G, et al: CKD prevalence varies across the European general population. J Am Soc Nephrol 2016; 27: 2135–2147.
3.
Vart P, Gansevoort RT, Joosten MM, et al: Socioeconomic disparities in chronic kidney disease: a systematic review and meta-analysis. Am J Prev Med 2015; 48: 580–592.
4.
Luyckx VA, Bertram JF, Brenner BM, et al: Effect of fetal and child health on kidney development and long-term risk of hypertension and kidney disease. Lancet 2013; 382: 273–283.
5.
Roberts CB, Couper DJ, Chang PP, et al: Influence of life-course socioeconomic position on incident heart failure in blacks and whites: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 2010; 172: 717–727.
6.
Loucks EB, Lynch JW, Pilote L, et al: Life-course socioeconomic position and incidence of coronary heart disease: the Framingham Offspring Study. Am J Epidemiol 2009; 169: 829–836.
7.
Smith BT, Lynch JW, Fox CS, et al: Life-course socioeconomic position and type 2 diabetes mellitus: the Framingham Offspring Study. Am J Epidemiol 2011; 173: 438–447.
8.
Whelan BJ, Savva GM: Design and methodology of the Irish Longitudinal Study on Ageing. J Am Geriatrs Soc 2013; 61(suppl 2):S265–S268.
9.
Kearney PM, Cronin H, O’Regan C, et al: Cohort profile: the Irish Longitudinal Study on Ageing. Int J Epidemiol 2011; 40: 877–884.
10.
Cronin H, O’Regan C, Finucane C, et al: Health and aging: development of the Irish Longitudinal Study on Ageing health assessment. J Am Geriatr Soc 2013; 61(suppl 2): S269–S278.
11.
Inker LA, Schmid CH, Tighiouart H, et al: Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012; 367: 20–29.
12.
Grubb A, Blirup-Jensen S, Lindstrom V, et al: First certified reference material for cystatin C in human serum ERM-DA471/IFCC. Clin Chem Lab Med 2010; 48: 1619–1621.
13.
Leahy S, O’ Halloran AM, O’ Leary N, et al: Prevalence and correlates of diagnosed and undiagnosed type 2 diabetes mellitus and pre-diabetes in older adults: findings from the Irish Longitudinal Study on Ageing -(TILDA). Diabetes Res Clin Pract 2015; 110: 241–249.
14.
McCrory C, Henretta JC, O’Connell MDL, et al: Intergenerational occupational mobility and objective physical functioning in midlife and older ages. J Gerontol B Psychol Sci Soc Sci 2018; 73: 279–291.
15.
Shoham DA, Vupputuri S, Diez Roux AV, et al: Kidney disease in life-course socioeconomic context: the Atherosclerosis Risk in Communities (ARIC) study. Am J Kidney Dis 2007; 49: 217–226.
16.
Shoham DA, Vupputuri S, Kaufman JS, et al: Kidney disease and the cumulative burden of life course socioeconomic conditions: the Atherosclerosis Risk in Communities (ARIC) study. Soc Sci Med 2008; 67: 1311–1320.
17.
Kramer MS, Seguin L, Lydon J, et al: Socio-economic disparities in pregnancy outcome: why do the poor fare so poorly? Paediatr Perinat Epidemiol 2000; 14: 194–210.
18.
Brenner BM, Garcia DL, Anderson S: Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens 1988; 1: 335–347.
19.
White SL, Perkovic V, Cass A, et al: Is low birth weight an antecedent of CKD in later life? A systematic review of observational studies. Am J Kidney Dis 2009; 54: 248–261.
20.
Bertram JF, Douglas-Denton RN, Diouf B, et al: Human nephron number: implications for health and disease. Pediatr Nephrol 2011; 26: 1529–1533.
21.
Hughson M, Farris AB 3rd, Douglas-Denton R, et al: Glomerular number and size in autopsy kidneys: the relationship to birth weight. Kidney Int 2003; 63: 2113–2122.
22.
Li S, Chen SC, Shlipak M, et al: Low birth weight is associated with chronic kidney disease only in men. Kidney Int 2008; 73: 637–642.
23.
Silverwood RJ, Pierce M, Hardy R, et al: Low birth weight, later renal function, and the roles of adulthood blood pressure, diabetes, and obesity in a British birth cohort. Kidney Int 2013; 84: 1262–1270.
24.
Maty SC, Lynch JW, Raghunathan TE, et al: Childhood socioeconomic position, gender, adult body mass index, and incidence of type 2 diabetes mellitus over 34 years in the Alameda County Study. Am J Public Health 2008; 98: 1486–1494.
25.
Levey AS, Bosch JP, Lewis JB, et al: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461–470.
26.
Stevens LA, Schmid CH, Greene T, et al: Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis 2010; 56: 486–495.
27.
Matsushita K, Mahmoodi BK, Woodward M, et al: Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA 2012; 307: 1941–1951.
28.
Stringhini S, Carmeli C, Jokela M, et al: Socioeconomic status and the 25 × 25 risk factors as determinants of premature mortality: a multicohort study and meta-analysis of 1.7 million men and women. Lancet 2017; 389: 1229–1237.
29.
Whelan B: RANSAM: a national random sampling design for Ireland. Econ Soc Rev 1979; 10: 169–174.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.